Replies to post #410803 on Amarin Corp Plc (AMRN)

[Chromosome]

Small world...off AMRN topic but I used to work at a company called ZS Pharma (acquired by AZ) that had a product for hyperkalemia called Lokelma competing directly with Veltassa. Consensus was it was better than Veltassa (quicker to reduce elevated potassium levels) but after two CRL's we lost market momentum and since then and despite approval and a better product profile, hospital pharmacy formularies are reluctant to add it as there is too much inertia. Its amazing how slowly things move in healthcare (unless its cancer).

[CaptBeer]

I guess it depends on who attended and how many.

[ziploc_1]

KIWI...The difference between innovations in the corporate word and in the medical world is that profits in the corporate world are directly tied to these innovations...For Doctors, innovations help patients,, but they don't necessarily do much to help the Doc's income ...and Docs are always dealing with the fear of malpractice suits when they use a new method of treatment...even if that method has been proven scientifically to be effective...Most Docs want other Docs to lead the way in using a new treatment on patients....Once they see that happening, they jump on the band wagon...Then they have a fear of malpractice if they do not use it.

This happened with the introduction of phaco-emulsification of cataracts, which initially lead to many lawsuits, but which are now the standard procedure for cataract operations.